
Almost all of us know someone who suffers from an autoimmune disease. Or maybe you do yourself. Autoimmune diseases are common: only cancer and cardiovascular diseases are more prevalent. So how do you fight a body that is fighting against itself? argenx, an immunology innovation company that develops antibody-based therapies, is developing a new toolkit of molecules that can tamp down the rebelling part of the immune system. Scientific American Custom Media recently talked to argenx’s new CEO, Karen Massey about what's in the toolkit -- and how it's helping patients. This podcast was produced for argenx by Scientific American Custom Media, a division separate from the magazine's board of editors. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Summer Reading Challenge: Quantum queerness, Pompeii and plant horror

Your summer reading list starts here

Are we too afraid of the sun?

Ebola update, World Cup heat risks, dad brains
Free AI-powered recaps of Science Quickly and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.